Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Bilcare Ltd

NSE: BI · BSE: 526853 · Healthcare · 18 announcements

Share price
₹95.01
Market cap
₹223.7 Cr
Revenue (annual)
₹733.5 Cr
Net profit (annual)
₹1.72 Cr
P/E (TTM)
28.8×Sector 53.1×
Promoter holding
30.01%+0.00% QoQ
FII holding
0.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:03 IST BSE
Annual General Meeting

Bilcare Annual General Meeting

Bilcare Limited issued a corrigendum for its 39th Annual General Meeting, correcting a clerical error where a director's appointment resolution was mislabeled as a special resolution.

12:16 IST BSE
Capital Structure Change

Bilcare Capital Structure Change

Non-promoter Guttikonda Anuradha, Vara Lakshmi and Rajasekhar bought 4,73,264 Bilcare shares in the open market, lifting PAC holdings to 16.47%. No transaction price was disclosed.

01:25 IST BSE
Management Change

Bilcare Management Change

Bilcare Limited has appointed Mr. Mohan Bhandari and re-appointed Ms. Kavita Bhansali as Executive Directors for a three-year term, effective August 2026.

22:57 IST BSE
Annual General Meeting

Bilcare Annual General Meeting

Bilcare Limited issued the Notice for its 39th Annual General Meeting scheduled for September 26, 2026, to transact six agenda items, including related party transaction approvals.

10:38 IST BSE
Capital Structure Change

Bilcare Capital Structure Change

Non-promoters Guttikonda Anuradha, Vara Lakshmi, and Rajasekhar sold 6,15,180 shares of Bilcare Ltd via open market on August 19, 2026.

00:11 IST BSE
Management Change

Bilcare Management Change

Bilcare Limited appointed Mohan Bhandari and Kavita Bhansali as Executive Directors. The company also announced the resignation of Company Secretary Sagar R. Baheti and appointment of Mayur Dave.

23:51 IST BSE
Board Meeting Date

Bilcare Board Meeting Date

Bilcare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the June quarter.